NantHealth, Inc. (NH) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
NantHealth, Inc. (NH) trades at $1.35 with AI Score 52/100 (Grade B). NantHealth, Inc. is a healthcare IT company focused on delivering clinical decision support and improving payer-provider communication. Sector: Healthcare.
Price as of Jul 23, 2026 · Last analyzed: May 10, 2026Analyst Coverage for NH: NH does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates NH against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
NH: 1/3 scored disciplines lean bearish. Dominant signal: Seth Klarman bearish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
NantHealth, Inc. (NH) Healthcare & Pipeline Overview
NantHealth, Inc. provides healthcare IT solutions, including clinical decision support and payer-provider communication platforms, primarily through its Eviti and NaviNet offerings. The company aims to improve healthcare efficiency and outcomes by centralizing clinical content and streamlining administrative processes within the healthcare ecosystem in the US, Canada, and the UK.
What Is the Investment Thesis for NH?
NantHealth, Inc. operates in the healthcare IT sector, which is experiencing growth due to the increasing demand for efficient data management and streamlined communication between healthcare providers and payers. The company's Eviti and NaviNet platforms address critical needs in cancer care management and payer-provider collaboration. However, with a profit margin of -101.2%, the company needs to demonstrate a clear path to profitability. Key catalysts include expanding the adoption of Eviti Connect for pre-authorization automation and leveraging NaviNet AllPayer to capture a larger share of the payer-provider communication market. The investment thesis hinges on NantHealth's ability to scale its SaaS solutions and achieve operational efficiencies to improve its financial performance.
Based on FMP financials and quantitative analysis
NH Key Highlights
- NantHealth operates in the healthcare IT sector, focusing on clinical decision support and payer-provider communication.
- The company's Eviti platform offers SaaS-based clinical decision support, centralizing treatment data and cost information.
- NaviNet is a suite of SaaS solutions designed to streamline communication between payers and providers.
- NantHealth's profit margin is -101.2%, indicating significant losses relative to revenue.
- Gross margin stands at 57.0%, suggesting potential for profitability with improved operational efficiency.
Who Are NH's Competitors?
NH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| VEEV Veeva Systems Inc. | $179.58 | -2.69% | $29.2B | 84 |
| GEHC GE HealthCare Technologies Inc. | $61.99 | +0.94% | $28.2B | 63 |
| BTSGU BrightSpring Health Services, Inc. Tangible Equity Unit | $230.25 | +0.48% | $13.8B | 90 |
| BTSG BrightSpring Health Services, Inc. | $69.84 | +0.14% | $13.7B | 91 |
| PMCUF Pro Medicus Limited | $114.00 | -5.79% | $11.9B | 59 |
| HQY HealthEquity, Inc. | $94.33 | -1.69% | $7.89B | 93 |
| DOCS Doximity, Inc. | $20.45 | -0.20% | $3.82B | 94 |
| ONEM ONEM | $16.47 | +0.00% | $3.40B | 55 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are NH's Key Strengths?
- Comprehensive clinical decision support with Eviti platform.
- Established payer-provider communication platform with NaviNet.
- SaaS-based business model provides recurring revenue.
- Offers data analytics solutions through Quadris.
What Are NH's Weaknesses?
- Negative profit margin (-101.2%) indicates financial instability.
- High beta (1.82) suggests high volatility compared to the market.
- Dependence on NantWorks, LLC.
- Limited geographic presence compared to larger competitors.
What Could Drive NH Stock Higher?
- Expansion of Eviti Connect adoption for pre-authorization automation among payers.
- Increasing NaviNet AllPayer reach to more commercial and government plans to streamline provider communication.
- Leveraging Quadris data solutions to provide actionable insights to healthcare providers and payers.
- Strategic partnerships with EHR vendors and population health management companies to expand product offerings.
What Are the Key Risks for NH?
- Financial-distress signal — its Altman Z-Score of -13.11 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Intense competition from established healthcare IT vendors like Allscripts and Cerner.
- Regulatory changes in healthcare impacting reimbursement and data privacy (e.g., HIPAA).
- Cybersecurity threats and data breaches compromising patient data.
- Negative profit margin (-101.2%) raises concerns about financial sustainability.
- Economic downturn affecting healthcare spending and IT investments.
What Are the Growth Opportunities for NH?
- Expansion of Eviti Connect: NantHealth can drive growth by expanding the adoption of Eviti Connect, its pre-authorization automation solution for cancer care. The market for pre-authorization automation is growing as payers seek to streamline administrative processes and reduce costs. By demonstrating the value of Eviti Connect in improving efficiency and reducing denial rates, NantHealth can capture a larger share of this market. Timeline: Ongoing.
- Increased Adoption of NaviNet AllPayer: NaviNet AllPayer provides eligibility, benefit, and claim status information to provider offices, streamlining communication with payers. The market for payer-provider communication platforms is expanding as healthcare providers seek to reduce administrative burdens and improve revenue cycle management. By expanding the reach of NaviNet AllPayer to more commercial and government plans, NantHealth can increase its market share. Timeline: Ongoing.
- Leveraging Quadris Data Solutions: NantHealth's Quadris data solution offers multi-data analysis, reporting, and professional services. The market for healthcare data analytics is growing as healthcare organizations seek to improve clinical outcomes, reduce costs, and optimize operations. By leveraging Quadris to provide actionable insights to healthcare providers and payers, NantHealth can drive revenue growth. Timeline: Ongoing.
- Strategic Partnerships and Integrations: NantHealth can pursue strategic partnerships and integrations with other healthcare IT vendors to expand its reach and enhance its product offerings. For example, integrating Eviti with leading EHR systems can improve clinical decision support and drive adoption. Partnering with population health management companies can enhance NantHealth's data analytics capabilities. Timeline: Ongoing.
- Geographic Expansion: NantHealth currently operates in the United States, Canada, and the United Kingdom. Expanding into new geographic markets, such as Europe and Asia-Pacific, can drive revenue growth. These markets offer significant opportunities for healthcare IT solutions that improve efficiency and outcomes. However, geographic expansion requires careful planning and execution to navigate regulatory and cultural differences. Timeline: Unknown.
What Opportunities Does NH Have?
- Expanding Eviti Connect adoption for pre-authorization automation.
- Increasing NaviNet AllPayer reach to more commercial and government plans.
- Leveraging Quadris for healthcare data analytics market growth.
- Strategic partnerships with EHR vendors and population health management companies.
What Threats Does NH Face?
- Intense competition from established healthcare IT vendors.
- Regulatory changes in healthcare impacting reimbursement and data privacy.
- Cybersecurity threats and data breaches.
- Economic downturn affecting healthcare spending.
What Are NH's Competitive Advantages?
- Proprietary Technology: NantHealth's Eviti platform has a comprehensive library of evidence-based treatment standards and protocols.
- Established Customer Base: The company has an established customer base of healthcare providers and payers.
- Data Network Effects: The NaviNet platform benefits from network effects as more payers and providers join the platform, increasing its value to all users.
What Does NH Do?
NantHealth, Inc., established in 2010 and headquartered in Morrisville, North Carolina, operates as a healthcare IT company with a focus on delivering solutions that enhance clinical decision support and streamline payer-provider communication. As a subsidiary of NantWorks, LLC, NantHealth has evolved to offer a suite of software and data solutions designed to improve healthcare efficiency and outcomes. Its flagship product, Eviti, is a SaaS-based clinical decision support solution that centralizes clinical content, treatment cost data derived from Medicare reimbursements, and treatment toxicity data. Eviti is complemented by Eviti Connect, which automates pre-authorization processes to help payers and providers navigate the complexities of cancer care, and Eviti Advisor, which provides physicians with access to evidence-based treatment standards and protocols. NantHealth also offers NaviNet, a suite of SaaS-based solutions that streamline communication and consolidate information between payers and providers. This includes NaviNet Open, a payer-provider collaboration platform, and NaviNet AllPayer, which provides eligibility, benefit, and claim status information for commercial and government plans, including Medicare beneficiaries. Additionally, the company provides OpenNMS, an open-source network monitoring solution for enterprise-grade networks, and Quadris, a data solution offering multi-data analysis, reporting, and professional services. NantHealth serves healthcare providers, payers, and other stakeholders across the United States, Canada, and the United Kingdom, aiming to improve healthcare delivery through technology.
What Products and Services Does NH Offer?
- Offers Eviti, a SaaS-based clinical decision support solution for cancer treatment.
- Provides Eviti Connect, which automates pre-authorization for cancer care.
- Offers Eviti Advisor, providing physicians access to evidence-based treatment protocols.
- Delivers NaviNet, a suite of SaaS-based solutions for payer-provider communication.
- Provides NaviNet Open, a payer-provider collaboration platform.
- Offers NaviNet AllPayer, providing eligibility and claim status information.
- Provides OpenNMS, an open-source network monitoring solution.
- Offers Quadris, a data solution for multi-data analysis and reporting.
How Does NH Make Money?
- Software-as-a-Service (SaaS): NantHealth generates revenue through subscription fees for its Eviti and NaviNet platforms.
- Data Solutions: The company offers data analysis, reporting, and professional services through its Quadris solution, generating revenue through service fees.
- Enterprise Solutions: NantHealth provides enterprise-grade network monitoring solutions through OpenNMS, generating revenue through licensing and support agreements.
What Industry Does NH Operate In?
NantHealth operates within the healthcare IT sector, which is characterized by increasing demand for solutions that improve efficiency, reduce costs, and enhance patient outcomes. The market is driven by factors such as the growing adoption of electronic health records (EHRs), the need for better data analytics, and the increasing focus on value-based care. The competitive landscape includes established players like Allscripts Healthcare Solutions and Cerner Corporation, as well as emerging companies offering specialized solutions. NantHealth differentiates itself through its focus on cancer care management with the Eviti platform and its payer-provider collaboration platform, NaviNet.
Who Are NH's Key Customers?
- Healthcare Providers: Physicians, hospitals, and cancer centers use NantHealth's Eviti platform for clinical decision support.
- Healthcare Payers: Insurance companies and managed care organizations use NaviNet to streamline communication and pre-authorization processes.
- Enterprise Clients: Organizations with large networks use OpenNMS for network monitoring.
Company Profile
NantHealth, Inc. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Morrisville, US. The company is led by CEO Patrick Soon-Shiong F.A.C.S., FACS, FRCS (C),. NH has traded publicly since 2016.
How NantHealth, Inc. Is Valued
Relative to its peer group, NH's quantitative score of 52/100 is below the peer average of 77/100.
ROE 35%Key Financial Metrics
Return on equity for NantHealth, Inc. stands at 35.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -42.5%, showing how much profit it generates from its asset base. A current ratio of 0.35 means current liabilities exceed short-term assets, a liquidity point worth watching.
F-Score 3/9Financial Health
NantHealth, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -13.11 places it in the distress zone, a signal of elevated financial risk.
NH Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Comprehensive clinical decision support with Eviti platform.
- Established payer-provider communication platform with NaviNet.
- SaaS-based business model provides recurring revenue.
- Offers data analytics solutions through Quadris.
Bear Case
- Negative profit margin (-101.2%) indicates financial instability.
- High beta (1.82) suggests high volatility compared to the market.
- Dependence on NantWorks, LLC.
- Limited geographic presence compared to larger competitors.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
NH Latest News
NH Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for NH.
Price Targets
Wall Street price target analysis for NH.
NH MoonshotScore
What does this score mean?
The MoonshotScore rates NH 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Patrick Soon-Shiong F.A.C.S., FACS, FRCS (C),
CEO
Patrick Soon-Shiong is a surgeon, scientist, and entrepreneur. He received his medical degree from the University of Witwatersrand in South Africa. He is the founder of NantWorks, a network of health, energy, commerce and communication companies. He previously founded Abraxis BioScience, which was acquired by Celgene. He has also been involved in various philanthropic endeavors, including cancer research and healthcare initiatives.
Track Record: Under Dr. Soon-Shiong's leadership, NantHealth has focused on developing and deploying technology solutions to improve healthcare delivery. Key milestones include the development of the Eviti and NaviNet platforms, aimed at streamlining clinical decision support and payer-provider communication. The company has also focused on expanding its data analytics capabilities through the Quadris solution.
NH Healthcare Stock FAQ
What does the AI Score mean for NH?
NH holds an AI Score of 52/100 (Grade: B). This is an educational research signal, not a buy or sell recommendation. NantHealth, Inc. is a healthcare IT company focused on delivering clinical decision support and improving payer-provider communication. Their key offerings include the Eviti platform and NaviNet …
What does NantHealth, Inc. do?
NantHealth, Inc. operates as a healthcare IT company, providing solutions to streamline clinical decision support and enhance payer-provider communication. Its core offerings include the Eviti platform, a SaaS-based clinical decision support tool that centralizes clinical content, treatment cost data, and treatment toxicity data, primarily focused on cancer care.
What do analysts say about NH stock?
Analyst coverage of NantHealth, Inc. is Unknown. Key valuation metrics and growth considerations are focused on the company's ability to scale its SaaS solutions, particularly Eviti and NaviNet, and achieve profitability. The company's financial performance, including its negative profit margin, is a significant factor in analyst evaluations. Investors should conduct their own due diligence and consider the risks and uncertainties associated with the company's financial performance and competitive landscape.
What are the main risks for NH?
NantHealth, Inc. faces several risks, including intense competition from established healthcare IT vendors, regulatory changes impacting reimbursement and data privacy, and potential cybersecurity threats. The company's negative profit margin also poses a significant risk, raising concerns about its financial sustainability. Furthermore, economic downturns could affect healthcare spending and IT investments, impacting NantHealth's revenue growth. Investors should carefully consider these risks before investing in NantHealth, Inc.
What are the key factors to evaluate for NH?
NantHealth, Inc. (NH) holds an AI score of 52/100 (moderate). Not financial advice.
How frequently does NH data refresh on this page?
NH's price was last updated on Jul 23, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven NH's recent stock price performance?
NantHealth, Inc. (NH) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Comprehensive clinical decision support with Eviti platform. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider NH overvalued or undervalued right now?
NantHealth, Inc. (NH) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research NH before investing?
Before investing in NantHealth, Inc. (NH), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- Competitive landscape assessment is based on publicly available information and may not be exhaustive.